[go: up one dir, main page]

IL141166A0 - New compounds - Google Patents

New compounds

Info

Publication number
IL141166A0
IL141166A0 IL14116699A IL14116699A IL141166A0 IL 141166 A0 IL141166 A0 IL 141166A0 IL 14116699 A IL14116699 A IL 14116699A IL 14116699 A IL14116699 A IL 14116699A IL 141166 A0 IL141166 A0 IL 141166A0
Authority
IL
Israel
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
IL14116699A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL141166A0 publication Critical patent/IL141166A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL14116699A 1998-08-21 1999-08-18 New compounds IL141166A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (1)

Publication Number Publication Date
IL141166A0 true IL141166A0 (en) 2002-02-10

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14116699A IL141166A0 (en) 1998-08-21 1999-08-18 New compounds

Country Status (20)

Country Link
US (3) US6579884B1 (xx)
EP (2) EP1411056A3 (xx)
JP (1) JP2002523415A (xx)
KR (1) KR20010072798A (xx)
CN (1) CN1329613A (xx)
AR (1) AR020226A1 (xx)
AT (1) ATE280768T1 (xx)
AU (1) AU5767999A (xx)
BR (1) BR9913103A (xx)
CA (1) CA2339286A1 (xx)
DE (1) DE69921483T2 (xx)
DK (1) DK1105391T3 (xx)
ES (1) ES2229763T3 (xx)
IL (1) IL141166A0 (xx)
NO (1) NO20010860L (xx)
PT (1) PT1105391E (xx)
SE (1) SE9802794D0 (xx)
SI (1) SI1105391T1 (xx)
WO (1) WO2000011000A2 (xx)
ZA (1) ZA200100913B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
KR20050072090A (ko) * 2002-09-19 2005-07-08 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 피라졸로피리딘
KR20050052500A (ko) * 2002-09-19 2005-06-02 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 이미다조피리딘
HRP20050399B1 (hr) 2003-03-10 2013-09-30 Takeda Gmbh Novi postupci za dobivanje roflumilasta
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
US20080280944A1 (en) 2003-11-03 2008-11-13 Paula Fernstrom Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux
US20080033006A1 (en) * 2004-01-26 2008-02-07 Altana Pharma Ag 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
KR101913531B1 (ko) * 2004-07-28 2018-10-30 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
EP2099798A1 (en) 2006-12-01 2009-09-16 Galapagos N.V. Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
AU2008304231A1 (en) * 2007-09-27 2009-04-02 Albany Molecular Research, Inc. Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
RU2586276C2 (ru) 2009-07-09 2016-06-10 Раквалиа Фарма Инк. Антагонист кислотного насоса для лечения заболеваний, связанных с патологическим нарушением моторики желудочно-кишечного тракта
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法
WO2025058459A1 (ko) * 2023-09-15 2025-03-20 (주)휴온스 신규한 이미다조피리딘계 화합물 및 이를 유효성분으로 포함하는 위장관 염증질환 또는 위산-관련 질환의 예방, 개선 또는 치료용 조성물
KR102902555B1 (ko) * 2023-09-15 2025-12-24 (주)휴온스 신규한 이미다조피리딘계 화합물 및 이를 유효성분으로 포함하는 위장관 염증질환 또는 위산-관련 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE59409983D1 (de) 1993-04-22 2002-01-10 Byk Gulden Lomberg Chem Fab Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
UA48122C2 (uk) 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
CA2196076A1 (en) 1994-07-28 1996-02-08 Gerhard Grundler Acyl imidazopyridines
EP0773944A1 (de) 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Benzylimidazopyridine
CA2196078A1 (en) 1994-07-28 1996-02-08 Gerhard Grundler Imidazopyridine-azolidinones
EP0772614A1 (de) 1994-07-28 1997-05-14 Byk Gulden Lomberg Chemische Fabrik GmbH Halogenimidazopyridine
DE19602853A1 (de) 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
WO1997027192A1 (de) 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh 3-methylimidazopyridine
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
JP2002523415A (ja) 2002-07-30
CN1329613A (zh) 2002-01-02
CA2339286A1 (en) 2000-03-02
EP1411056A3 (en) 2004-04-28
DK1105391T3 (da) 2005-01-24
US20030220364A1 (en) 2003-11-27
NO20010860L (no) 2001-04-23
US20050154007A1 (en) 2005-07-14
NO20010860D0 (no) 2001-02-20
AR020226A1 (es) 2002-05-02
EP1105391A2 (en) 2001-06-13
PT1105391E (pt) 2005-01-31
ES2229763T3 (es) 2005-04-16
ZA200100913B (en) 2002-05-02
EP1411056A2 (en) 2004-04-21
AU5767999A (en) 2000-03-14
KR20010072798A (ko) 2001-07-31
DE69921483T2 (de) 2006-02-02
US6579884B1 (en) 2003-06-17
SE9802794D0 (sv) 1998-08-21
SI1105391T1 (en) 2005-02-28
US6790960B2 (en) 2004-09-14
WO2000011000A2 (en) 2000-03-02
EP1105391B1 (en) 2004-10-27
WO2000011000A3 (en) 2000-06-15
BR9913103A (pt) 2001-05-08
ATE280768T1 (de) 2004-11-15
DE69921483D1 (de) 2004-12-02

Similar Documents

Publication Publication Date Title
GB9804734D0 (en) Compounds
GB9804175D0 (en) Compounds
IL141166A0 (en) New compounds
GB9818689D0 (en) Compounds
GB9818881D0 (en) Compounds
GB9821977D0 (en) Compounds
GB9809823D0 (en) Compounds
GB9810876D0 (en) Compounds
GB9822140D0 (en) Compounds
GB9812522D0 (en) Compounds
GB9809217D0 (en) Compounds
HUP0101446A3 (en) New compounds
GB9809988D0 (en) Compounds
GB9816983D0 (en) Compounds
GB9806379D0 (en) Compounds
GB9820403D0 (en) Compounds
GB9806701D0 (en) Compounds
GB9807756D0 (en) Compounds
GB9808813D0 (en) Compounds
GB9805447D0 (en) Compounds
GB9805446D0 (en) Compounds
GB9800834D0 (en) Compounds
GB9805132D0 (en) Compounds
GB9803611D0 (en) Compounds
GB9812140D0 (en) Compounds